IM Medical Limited proposed to undertake a pro-rata non-renounceable entitlements issue on the basis of 3 new fully paid ordinary shares in the Company (Shares) for every 8 existing Shares held by eligible shareholders at an issue price of $0.001 per Share. If the Babylon Acquisition completes, it is expected that Mr. Michael Shelby, Mr. Patrick Mainguard and Mr. Michael Kenyon will be appointed to the Board of the company, and the existing directors of IMI will resign from the IMI Board. It is also intended that Mr. Kenyon will be appointed as Company Secretary of IMI.